Congressman Donald Norcross

Representing the 1st District of New Jersey
Mobile Menu - OpenMobile Menu - Closed

Norcross Legislation to Combat Opioid Epidemic Moves Forward in House

Apr 26, 2018
News Release

WASHINGTON, DC – Today, Congressman Donald Norcross (NJ-01) applauded the House Energy & Commerce Health Subcommittee’s passage of legislation to help those struggling with the disease of addiction. The legislation includes provisions originally introduced and supported by Norcross.

“In New Jersey, deaths from heroin and fentanyl overdoses more than tripled in the last five years. That’s tragic and unacceptable. We must invest time, effort and money to save lives,” said Congressman Donald Norcross, Vice-Chair of the Bipartisan Task Force to Combat the Heroin Epidemic. “These policy solutions include innovative approaches to get medical professionals the information they need, prevent ‘doctor shopping’ and help our children, grandchildren, spouses, friends and neighbors who are struggling with the disease of addiction.”

Norcross added: “Congress has taken a step in the right direction, but we still need to do more to help curb the opioid epidemic. Leaders in Congress and the Administration should advance the whole suite of bills supported by the Bipartisan Heroin Task Force because one preventable death is too many.”

The Subcommittee legislation includes:

  • The STOP Fentanyl Deaths Act, a bill Norcross helped introduce, which provides grant funding to assist states and municipalities in identifying fentanyl in both fatal and nonfatal drug overdoses, and creates a pilot program allowing states to develop unique ‘point of use’ drug testing programs.
  • Jessie’s Law, a bill co-sponsored by Norcross, which helps ensure doctors have access to a consenting patient's prior history of addiction in order to make fully informed care and treatment decisions.
  • The Every Prescription Conveyed Securely Act, a bill co-sponsored by Norcross, which prevents ‘doctor shopping’ and requires all prescriptions for controlled substances through Medicare Part D to be transmitted electronically.

Recent, Related Content


Contact: Ally Kehoe, Communications Director